Latest biopharmaceutical Stories
Stemedica Cell Technologies, Inc., a specialty biopharmaceutical company that manufactures best-in-class allogeneic adult stem cells and Smart Living, a subsidiary of Smart Global, a $2 billion
LA JOLLA, Calif., March 24, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc.
MONROVIA, Calif., March 24, 2014 /PRNewswire/ -- Xencor, Inc.
MedVax Technologies, Inc., a biopharmaceutical company developing and commercializing cancer vaccine immunotherapies, announced today that Robert Brooks, Chief Executive Officer, will be presenting
All amounts are in US dollars QUEBEC CITY, March 20, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a specialty biopharmaceutical company
JUPITER, Fla., March 18, 2014 /PRNewswire/ -- Dyadic International, Inc.
-- ABRAXANE plus gemcitabine approved by the TGA for the first-line treatment of metastatic pancreatic cancer MELBOURNE, Australia, March 18, 2014 /PRNewswire/ -- Australian biopharmaceutical
CAMBRIDGE, England, March 16, 2014 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company founded on research from the Wellcome Trust
GHENT, Belgium, March 14, 2014 /PRNewswire/ -- ActoGeniX NV, creator of ActoBiotics(TM), announced today that Bernard Coulie, Chief Executive Officer, will present a company overview at the
MONROVIA, Calif., March 13, 2014 /PRNewswire/ -- Xencor, Inc.
- A coin originally worth six pennies Scots, and later three; held equivalent to an English halfpenny.
- (in plural) Money; cash.